These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 36685214)

  • 1. Single-cell transcriptomics: A new tool for studying diabetic kidney disease.
    Mao ZH; Gao ZX; Liu Y; Liu DW; Liu ZS; Wu P
    Front Physiol; 2022; 13():1053850. PubMed ID: 36685214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell RNA-seq with spatial transcriptomics to create an atlas of human diabetic kidney disease.
    Chen D; Shao M; Song Y; Ren G; Guo F; Fan X; Wang Y; Zhang W; Qin G
    FASEB J; 2023 Jun; 37(6):e22938. PubMed ID: 37130011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.
    Zhao J; He K; Du H; Wei G; Wen Y; Wang J; Zhou X; Wang J
    PeerJ; 2022; 10():e13932. PubMed ID: 36157062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hub genes in diabetic kidney disease via multiple-microarray analysis.
    Zhang Y; Li W; Zhou Y
    Ann Transl Med; 2020 Aug; 8(16):997. PubMed ID: 32953797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The study of single cells in diabetic kidney disease.
    Kaur H; Advani A
    J Nephrol; 2021 Dec; 34(6):1925-1939. PubMed ID: 33476038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational solutions for spatial transcriptomics.
    Kleino I; Frolovaitė P; Suomi T; Elo LL
    Comput Struct Biotechnol J; 2022; 20():4870-4884. PubMed ID: 36147664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of differentially expressed genes in diabetic kidney disease by RNA-Seq analysis of venous blood platelets.
    Zhang BL; Yang XH; Jin HM; Zhan XL
    FEBS Open Bio; 2021 Aug; 11(8):2095-2109. PubMed ID: 34029013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel key genes and potential candidate small molecule drugs in diabetic kidney disease using comprehensive bioinformatics analysis.
    Li B; Ye S; Fan Y; Lin Y; Li S; Peng H; Diao H; Chen W
    Front Genet; 2022; 13():934555. PubMed ID: 36035169
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease.
    Jung CY; Yoo TH
    Diabetes Metab J; 2022 Mar; 46(2):181-197. PubMed ID: 35385633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease.
    Hasegawa S; Inagi R
    Curr Diab Rep; 2021 May; 21(7):21. PubMed ID: 33974145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stratification of diabetic kidney diseases
    Huang Q; Fei X; Zhong Z; Zhou J; Gong J; Chen Y; Li Y; Wu X
    Front Endocrinol (Lausanne); 2022; 13():995362. PubMed ID: 36465646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Novel Key Molecular Signatures in the Pathogenesis of Experimental Diabetic Kidney Disease.
    Diao M; Wu Y; Yang J; Liu C; Xu J; Jin H; Wang J; Zhang J; Gao F; Jin C; Tian H; Xu J; Ou Q; Li Y; Xu G; Lu L
    Front Endocrinol (Lausanne); 2022; 13():843721. PubMed ID: 35432190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease.
    Pereira PR; Carrageta DF; Oliveira PF; Rodrigues A; Alves MG; Monteiro MP
    Med Res Rev; 2022 Jul; 42(4):1518-1544. PubMed ID: 35274315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel biomarkers for diabetic kidney disease.
    Jung CY; Yoo TH
    Kidney Res Clin Pract; 2022 Sep; 41(Suppl 2):S46-S62. PubMed ID: 36239061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum integrative omics reveals the landscape of human diabetic kidney disease.
    Liu S; Gui Y; Wang MS; Zhang L; Xu T; Pan Y; Zhang K; Yu Y; Xiao L; Qiao Y; Bonin C; Hargis G; Huan T; Yu Y; Tao J; Zhang R; Kreutzer DL; Zhou Y; Tian XJ; Wang Y; Fu H; An X; Liu S; Zhou D
    Mol Metab; 2021 Dec; 54():101367. PubMed ID: 34737094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
    Helou N; Dwyer A; Shaha M; Zanchi A
    JBI Database System Rev Implement Rep; 2016 Jul; 14(7):169-207. PubMed ID: 27532796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.
    Guo J; Liu Z; Gong R
    Clin Sci (Lond); 2019 Jun; 133(12):1321-1339. PubMed ID: 31221822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.
    Zheng W; Guo J; Liu ZS
    Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REG1A and RUNX3 Are Potential Biomarkers for Predicting the Risk of Diabetic Kidney Disease.
    Wang X; Wu H; Yang G; Xiang J; Xiong L; Zhao L; Liao T; Zhao X; Kang L; Yang S; Liang Z
    Front Endocrinol (Lausanne); 2022; 13():935796. PubMed ID: 35937821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression-based analysis identified NTNG1 and HGF as biomarkers for diabetic kidney disease.
    Tang YL; Dong XY; Zeng ZG; Feng Z
    Medicine (Baltimore); 2020 Jan; 99(1):e18596. PubMed ID: 31895808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.